Despite the volatility, several modalities demonstrated strong growth between 2014 and 2016.

Here’s a look at the top 3, all of which offer some interesting opportunities in key areas.

Download the complete report for more information.

Go Further

While our report offers a strong handle on these growth areas, it won’t let you know equipment counts for specific hospitals so you can see which ones offer the best sales opportunities. For that, you need the deep granular detail available in our hospital database, which lets you see equipment counts for nearly 70% of Argentina’s hospitals, key contacts for purchase and much more. Contact us to subscribe to our database so you can get started today on uncovering new sales from the Argentine hospital market.

Beyond that, we can also help with fresh data on market share so you can see where you stand in comparison to your competitors or deliver some custom research to further help you edge out the competition with crucial market intelligence.

A research study on access of medication in four Latin American countries was conducted by the National University of Colombia.

The study outlines the consumption of high-cost drugs reduces the accessibility for a large majority of the population in the middle and lower income groups.

The new medicines launched in the market come with high prices. This scenario forces health systems to prioritize and restrict their use to some patients. International studies have shown cases where the pharmaceutical industry encourages the prescription of expensive drugs with biased information.

People in the higher income bracket in general are more informed on the health services and can file legal actions against the State for accessing medicines that are not covered in the Obligatory Health Plan (POS).

The State spends more money on the purchase of few medicines reducing the access to basic health services for the poorest population. Such a crisis requires much broader solutions that include the reform of the healthcare model, so that greater emphasis is placed on preventive and health promotion actions.

The availability of big data in healthcare, rise in venture capital investments and technological advancements are other factors aiding in the market growth. Descriptive analytics accounted for the largest market share in 2016. The clinical analytics segment is expected to grow at the highest CAGR during the forecast period primarily attributed to growing adoption of analytics to curb healthcare costs.

There has been an increasing focus on personalized medicine-based analytics by healthcare providers. Factors such as dearth of skilled personnel, high cost of analytics solutions and operational gaps between payers and providers are some factors restraining the market growth. The market is witnessing an increasing focus on value-based medicine, social media and patient registries.

However, certain challenges including patient data confidentiality, inaccurate and inconsistent data and reluctance to adopt healthcare analytics in emerging countries prevail in the market.

Key market players include Allscripts Healthcare Solutions, Cerner Corporation, Health Catalyst, IBM Corporation, Inovalon Holdings, Mckesson Corporation, Medeanalytics, Optum (Part of Unitedhealth Group), Oracle Corporation, SAS Institute and Verisk Analytics.